Literature DB >> 15307839

Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients.

Hans Vlaminck1, Bart Maes, Georges Evers, Geert Verbeke, Evelyne Lerut, Boudewijn Van Damme, Yves Vanrenterghem.   

Abstract

In this prospective study we compared the incidence of late acute rejections (LAR) and changes in serum-creatinine over time between compliers and noncompliers with immunosuppressive therapy more than 1 year post transplantation and explored the relative contribution of non-compliance and other risk factors in the occurrence of LAR. One hundred and forty-six adult renal transplant recipients were followed during a 5-year period. Patients were interviewed at the beginning of the study and categorized as non-compliers if they admitted to have skipped immunosuppressive medication on a regular basis during the previous 12 months. The occurrence of LAR during the follow-up period was recorded. We identified 22.6% non-compliers of which 21.2% experienced a late acute rejection compared with 8% in the group of compliers at 5 years postinclusion (p < 0.05). Kaplan-Meier survival analysis showed a decreased rejection free time in non-compliers compared with compliers (p = 0.03). Non-compliant patients had a 3.2 higher risk of LAR (Cox regression analysis, p = 0.005). Non-compliers experienced a higher increase in serum-creatinine over time (Linear Mixed Models, p < 0.001). Non-compliance in renal transplant patients more than 1-year post transplantation is associated with an increased risk for LAR and a higher increase in serum-creatinine during the following 5 years. Copyright 2004 Blackwell Munksgaard

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15307839     DOI: 10.1111/j.1600-6143.2004.00537.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  48 in total

1.  Antidepressant medication use before and after kidney transplant: implications for outcomes - a retrospective study.

Authors:  Krista L Lentine; Abhijit S Naik; Rosemary Ouseph; Zidong Zhang; David A Axelrod; Dorry L Segev; Vikas R Dharnidharka; Daniel C Brennan; Henry Randall; Raj Gadi; Ngan N Lam; Gregory P Hess; Bertram L Kasiske; Mark A Schnitzler
Journal:  Transpl Int       Date:  2017-08-03       Impact factor: 3.782

Review 2.  Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation.

Authors:  Mary B Prendergast; Robert S Gaston
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 8.237

3.  Taking immunosuppressive medications effectively (TIMELink): a pilot randomized controlled trial in adult kidney transplant recipients.

Authors:  Cynthia Russell; Vicki Conn; Catherine Ashbaugh; Richard Madsen; Mark Wakefield; Andrew Webb; Deanna Coffey; Leanne Peace
Journal:  Clin Transplant       Date:  2010-11-16       Impact factor: 2.863

4.  Electronically measured adherence to immunosuppressive medications and kidney function after deceased donor kidney transplantation.

Authors:  Ajay K Israni; Francis L Weng; Ye-Ying Cen; Marshall Joffe; Malek Kamoun; Harold I Feldman
Journal:  Clin Transplant       Date:  2010-10-26       Impact factor: 2.863

5.  Psychosocial aftercare after organ transplantation.

Authors:  Uwe Wutzler; Margit Venner
Journal:  Dtsch Arztebl Int       Date:  2010-01-15       Impact factor: 5.594

Review 6.  Operational tolerance in kidney transplantation and associated biomarkers.

Authors:  A Massart; L Ghisdal; M Abramowicz; D Abramowicz
Journal:  Clin Exp Immunol       Date:  2017-05-29       Impact factor: 4.330

7.  Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled Trial.

Authors:  John W McGillicuddy; Jessica L Chandler; Luke R Sox; David J Taber
Journal:  Ann Pharmacother       Date:  2020-06-08       Impact factor: 3.154

8.  Clinical and pathological features of kidney transplant patients with concurrent polyomavirus nephropathy and rejection-associated endarteritis.

Authors:  Stephanie M McGregor; W James Chon; Lisa Kim; Anthony Chang; Shane M Meehan
Journal:  World J Transplant       Date:  2015-12-24

9.  Medication-taking among adult renal transplant recipients: barriers and strategies.

Authors:  Elisa J Gordon; Mary Gallant; Ashwini R Sehgal; David Conti; Laura A Siminoff
Journal:  Transpl Int       Date:  2009-01-16       Impact factor: 3.782

10.  Quantitative patterns of azathioprine adherence after renal transplantation.

Authors:  Thomas E Nevins; William Thomas
Journal:  Transplantation       Date:  2009-03-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.